Achelios Therapeutics Inc - Company Review
Achelios Therapeutics Inc - Company ReviewSummary
Achelios Therapeutics Inc (Achelios) is a biopharmaceutical development company that provides reformulation of non-steroidal anti-inflammatory (NSAID) drug molecules. The company offers therapeutic entity development for the treatment of pain and inflammation. Its lead product includes Topofen, which is developed for the indication of acute migraines. Achelios’ develops novel formulations using its proprietary Topogel delivery technology with the proven NSAID ketoprofen. The company’s formulations are used for the indications of migraine prophylaxis, osteoarthritis, sprains and strains, and temporomandibular joint disorders. It owns and operates a research laboratory located in San Diego, California, the US. Achelios is headquartered in Chapel Hill, North Carolina, the US.
This comprehensive company report of Achelios Therapeutics Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.